Next Generation Cancer Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Next Generation Cancer Diagnostics Market is expected to grow from $6.2 billion in 2020 to $16.7 billion by 2027 with a compound annual growth rate (CAGR) of 21% for the period of 2021-2027.

The next-generation cancer diagnostic device helps early detection and prevention of cancer. Researchers are constantly working to develop new cancer diagnostic tools and improve existing tools. Many market companies are collaborating to create new cancer biomarkers and assays, which is driving the market growth. Cancer diagnosis helps detect cancer early for better treatment options. Next-generation cancer diagnostics will help detect diseases with full accuracy at a lower cost.

Market Segmentation:

By Technology

• Next-Generation Sequencing
• qPCR & Multiplexing
• Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
• Protein Microarrays
• DNA Microarrays

By Cancer Type

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

Key Players

Prominent players in the next-generation cancer diagnostics market include Thermo Fisher Scientific, Inc; Opko Health, Inc;  Myriad Genetics, Inc.; Agilent Technologies; GE Healthcare Cepheid; Koninklijke Philips N.V; F. Hoffmann-La Roche Ltd; Qiagen; Novartis AG; Abbott; PerkinElmer, Inc.; Genomic Health, Inc.; Illumina, Inc; and Sysmex Corporation.

Scope of the Report

The research study analyzes the global Next Generation Cancer Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Next Generation Cancer Diagnostics Market Report

1. What was the Next Generation Cancer Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Next Generation Cancer Diagnostics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Next Generation Cancer Diagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.